|

MX006 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Myricx Pharma Limited1

Indications

  • Advanced and/or Metastatic Solid Tumors Known to Express B7-H31
  • Cancer1

Sarasota, Florida1 trial

A Study of MX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3

Florida Cancer Specialists

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.